Customer Service (Mon-Fri / 8-5): 877-723-7823

Outstanding Hematology/Oncology Position w/ Opportunity for Academic Appointment

Specialty: Hematology & Oncology

Posted: Mar 13, 2024
Apply Online
(Physicians Only)
Job Number:
Contact Name: Reyna Lute
Phone:

Facility:
Location: Urbana, Idaho
USA
Degree: MD
Board Status: N/A
Fellowship Required: No
Perm/Locum: See Notes - Perm
Workload: Full Time
Position Type:
  • Hospital
Date Posted: 03/13/2024
Contact Information
Job Number:
Contact Name: Reyna Lute
Phone:
Fax:

Apply Online
(Physicians Only)

Register to save time applying for jobs.

Outstanding Hematology/Oncology Position w/ Opportunity for Academic Appointment
Specialty: Hematology & Oncology

Physician - Hematology and Oncology Job in Urbana, IL

  • The practice has radiation oncology, surgical oncology, gynecologic oncology and breast surgery at Carle Cancer Center with colorectal surgery, interventional radiology, urology, neurosurgery, head and neck surgery, and thoracic surgery at Carle Foundation Hospital.
  • Academic appointment will be commensurate with qualifications and experience.
  • Carle Foundation Hospital is an equal opportunity employer committed to inclusive excellence through diversity.
  • Carle Cancer Center is a part of Carle Foundation Hospital and both are located at the same campus in Urbana allowing all services to be integrated into our Multi-disciplinary Cancer Care Model.
  • Candidates with experience and new graduates are very welcome. Mentorship for new graduates will be provided.
  • Both in-patient oncology unit and out-patient oncology clinic also have on staff Nurse Practitioner (NPs) who work with oncologists.
  • Leadership opportunities are available throughout the organization.
  • And a strong support from Radiation Oncology and all Surgical Services.
  • Of Illinois with more than 40,000 students.
  • Hematology/Oncology Physician would enjoy a very generous compensation package in a stable, vertically integrated Carle Health System, while practicing in a multi-disciplinary setting with Weekly Disease Specific Tumor Boards (Upper GI, Lower GI, Breast, Thoracic, etc.
  • Unfortunately, this position does not qualify for a J-1 visa waiver.
  • Champaign-Urbana is a home of the Univ.
  • In addition, Carle Cancer Center has a close collaboration with the Univ.
  • Epic electronic medical record is utilized.
  • In 2018, Carle and the Univ.
  • Carle Cancer Center is a home of Stephens Family Clinical Research Institute with an existing opportunity to support investigator initiated studies.
  • 100 open clinical trials for cancer patients in the East Central Illinois.
  • Training and interest in both Hematology and Oncology are required.
  • Carle Foundation Hospital is excited to add a BE/BC Hematology/Oncology Physician at Carle Cancer Center in Urbana, Illinois.
  • An interest in GI malignancies is a plus.
  • Of Illinois Basic Science Cancer Center in Urbana, Illinois.
  • For candidates with a strong academic background, a research component will be considered.
  • Of Illinois opened their doors to first medical student class at the new Carle Illinois College of Medicine.
  • The practice's main location is in Urbana, IL with several satellite locations in the East Central Illinois.
  • Carle Health system is one of the very few health systems in the nation to offer its own health insurance product - Health Alliance Medical Plans (Hamp).
  • This is a very cosmopolitan place with a variety of restaurants offering international cuisine and a proximity of two large metropolitan areas, Chicago and Indianapolis (only 2-hour drive).
  • Hematology/Oncology Physician would work with nine (9) other Oncologists in the practice.
  • Patients are admitted to the hospital by Hospitalists' Service.
  • The Hematology/Oncology Physician would practice at our main campus in Urbana with one day work per week at one of Carle's Hematology/Oncology satellite locations.
  • Carle Cancer Center has a strong clinical cancer research with a National Community Oncology Research Program (Ncorp) Grant from the National Cancer Institute (NCI) and currently.